(Q39519065)

12 September 2017

title

THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling (English)

1 reference

12 September 2017

0 references

1 reference

Susann Förster

1

1 reference

12 September 2017

Stephan Gretschel

2

1 reference

12 September 2017

Thomas Jöns

3

1 reference

12 September 2017

Masakazu Yashiro

4

1 reference

12 September 2017

Wolfgang Kemmner

5

1 reference

12 September 2017

publication date

24 June 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

24

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

1390-1403

1 reference

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Gastric adenocarcinoma: pathomorphology and molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Pathology and molecular biology of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Epithelial mesenchymal interactions in cancer and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Novel models for human scirrhous gastric carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Characterization of human thrombospondin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Gene expression based classification of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Transforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Thrombospondin-4, an extracellular matrix protein expressed in the developing and adult nervous system promotes neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

The C-terminal peptide of thrombospondin-4 stimulates erythroid cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Regulator of differentiation 1 (ROD1) binds to the amphipathic C-terminal peptide of thrombospondin-4 and is involved in its mitogenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Thrombospondin-4 binds specifically to both collagenous and non-collagenous extracellular matrix proteins via its C-terminal domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Gene expression profiling of mesoblastic nephroma and Wilms tumors--comparison and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

CD44 cell adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

CD44: structure, function, and association with the malignant process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Osteopontin and the C-terminal peptide of thrombospondin-4 compete for CD44 binding and have opposite effects on CD133+ cell colony formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Variation in gene expression patterns in human gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

Statistical significance for genomewide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

A direct approach to false discovery rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

7 January 2021

Gastric adenocarcinoma: review and considerations for future directions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

7 January 2021

The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

7 January 2021

Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

7 January 2021

A survival study of intestinal and diffuse types of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

7 January 2021

Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

7 January 2021

Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

7 January 2021

Differentiation of tumours of ductal and lobular origin: II. Genomics of invasive ductal and lobular breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.99

7 January 2021

10.1038/MODPATHOL.2011.99

Identifiers

DOI

1 reference

Dimensions Publication ID

12 September 2017

1044351541

0 references

Fatcat ID

release_egzbmm3mhngcrimtg5bpeaahyu

0 references

1 reference